(Q33335676)

25 July 2017

1 reference

title

Laboratory testing for heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

25 July 2017

1 reference

1 reference

1

Warkentin TE

1 reference

25 July 2017

publication date

1 November 2000

1 reference

Journal of Thrombosis and Thrombolysis

25 July 2017

published in

1 reference

25 July 2017

volume

10 Suppl 1

1 reference

25 July 2017

page(s)

35-45

1 reference

Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia

25 July 2017

cites work

1 reference

12 December 2020

Heparin-induced thrombocytopenia: towards consensus.

1 reference

12 December 2020

Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.

1 reference

12 December 2020

Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells

1 reference

12 December 2020

Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay

1 reference

12 December 2020

Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome

1 reference

12 December 2020

A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia.

1 reference

12 December 2020

Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

1 reference

12 December 2020

Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.

1 reference

12 December 2020

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

1 reference

12 December 2020

Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

1 reference

12 December 2020

Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid

1 reference

12 December 2020

Heparin-induced thrombocytopenia: a survey of tests employed and attitudes in haematology laboratories. Groupe d'Etude sur l'Hémostase et la Thrombose (GEHT) de la Société Française d'Hématologie

1 reference

12 December 2020

A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry

1 reference

12 December 2020

Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4)

1 reference

12 December 2020

Further characterization of antibody and antigen in heparin-induced thrombocytopenia

1 reference

12 December 2020

Characterization of the humoral immune response in heparin-induced thrombocytopenia

1 reference

12 December 2020

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

12 December 2020

Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations

1 reference

12 December 2020

Antiphospholipid antibodies and venous thromboembolism

1 reference

12 December 2020

Heparin-induced thrombocytopenia: a clinicopathologic syndrome

1 reference

12 December 2020

A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia

1 reference

12 December 2020

Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation

1 reference

12 December 2020

Heparin-induced thrombocytopenia: laboratory investigation and confirmation of diagnosis

1 reference

12 December 2020

A diagnostic test for heparin-induced thrombocytopenia

1 reference

12 December 2020

Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients

1 reference

12 December 2020

Heparin-Induced Thrombocytopenia With Thrombosis and Hemorrhage

1 reference

12 December 2020

Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia

1 reference

12 December 2020

The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia

1 reference

12 December 2020

Protein A antibody-capture ELISA (PACE): an ELISA format to avoid denaturation of surface-adsorbed antigens

1 reference

12 December 2020

Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen

1 reference

12 December 2020

First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA.

1 reference

12 December 2020

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

1 reference

12 December 2020

The epitope specificity of heparin-induced thrombocytopenia

1 reference

12 December 2020

Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.

1 reference

12 December 2020

A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

1 reference

12 December 2020

A prospective comparison of four techniques for measuring platelet-associated IgG.

1 reference

12 December 2020

The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia

1 reference

12 December 2020

Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods

1 reference

12 December 2020

Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1027381103184

1 reference

Dimensions Publication ID

25 July 2017

1005105092

0 references

1 reference